• Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney master your money
Moneycontrol

Home » News » Stocks Views

Feb 17, 2017, 12.06 PM | Source: CNBC-TV18

Vedanta may test Rs 270-272, says Hemant Thukral

Hemant Thukral, National Head-Derivative Desk at Aditya Birla Money is of the view that Vedanta may test Rs 270-272.

Like this story, share it with millions of investors on M3

Vedanta may test Rs 270-272, says Hemant Thukral

Hemant Thukral, National Head-Derivative Desk at Aditya Birla Money is of the view that Vedanta may test Rs 270-272.

Post Your Comments

Share Cancel

| 2 Comments

Hemant Thukral (more)

National Head- Derivative Desk, Aditya Birla Money | Capital Expertise: F&O

Hemant Thukral, National Head-Derivative Desk at Aditya Birla Money told CNBC-TV18, "The stocks that we are recommending today - one is metals stock,  Vedanta , the stock has seen a good amount of buying yesterday both in cash and F&O - 3 percent fresh open interest (OI) added up there. What was very interesting in that stock was the way 260 Call shares got unwinded, 19 lakh shares got unwinded and around 8 lakh shares got added up in 260 Put. So that means clearly the new base has come in place and I think now the stoploss can be Rs 258-260 band, which was acting as a resistance and the next target Vedanta should look at is around Rs 270-272 band."

He further added, " Bharat Forge  is on some serious upmove and that momentum will continue. The way the open interest has added up yesterday, 6 percent fresh longs have been added up. Technically stock has seen a clear breakout now above Rs 1,065, which was acting as a resistance in weekly charts also. So now we feel, it is heading towards Rs 1,125 to Rs 1,130 and one can keep a tight stoploss of Rs 1,060 from where it has given a breakout. So both these stocks are valid till February expiry that is next two-three trading sessions."

"I like  Aurobindo Pharma more. The way this stock has rebounded back after being battered down till Rs 625-630, it has been a very old support from where it has rebounded monthly support. We expect it to rebound that to Rs 660-662. So I would be looking out to buying opportunities in Aurobindo Pharma now," he said.
Buy, Hold, Sell ? Hear it first on M3
Vedanta may test Rs 270-272, says Hemant Thukral
New Member
7 Followers

Price when posted: NSE: Rs. 263.45

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login